Agios Pharmaceuticals, Inc. Stock Performance

Open $31.86	Prev. Close $32.10	Circuit Range N/A
Day Range $31.55 - $32.12	Year Range $22.25 - $46.00	Volume 39,899
Average Traded $31.91

Agios Pharmaceuticals, Inc. Share Price Today

As of 12 October 2026, Agios Pharmaceuticals, Inc.'s share price is $31.83. The stock opened at $31.86, compared to its previous close of $32.10. During today's trading session, Agios Pharmaceuticals, Inc.'s share price traded between $31.55 and $32.12, with an average price of $31.84. Over the past 52 weeks, the stock has recorded a high of $46.00 and a low of $22.25. In terms of performance, Agios Pharmaceuticals, Inc.'s share price has risen by 13.70% over the last six months and is down 26.42% on a year-on-year basis.

Agios Pharmaceuticals, Inc. Share Price Chart

$31.55$32.12

Agios Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap $1.85B	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-6.89	Revenue (TTM) $54.03B	Return On Equity (TTM) -40.09%
Profit Margin -763.98%	Debt to Equity 0.00	Quarterly Earnings Growth YoY 2.64%

Agios Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$12.88	$19.97	$20.75	$44.75
Net Profit	-$103.43	-$108.04	-$99.11	-$100.70
Net Profit Margin	-803.03%	-541.01%	-477.64%	-225.03%
Income Change	N/A	-4.46%	8.27%	-1.60%

Agios Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$14.24	$26.82	$36.50	$54.03
Net Profit	-$231.80	-$352.09	$673.73	-$412.78
Net Profit Margin	-1627.81%	-1312.79%	1845.84%	-763.98%
Income Change	N/A	-51.89%	291.35%	-161.27%

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Agios Pharmaceuticals, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$33.55	$31.80	-4.59%
Sep 2026	$33.70	$33.33	-2.81%
Aug 2026	$30.13	$34.30	+14.41%
Jul 2026	$37.17	$29.98	-19.22%
Jun 2026	$29.04	$37.10	+26.23%
May 2026	$28.02	$29.39	+5.00%
Apr 2026	$33.89	$28.00	-17.25%
Mar 2026	$29.25	$33.83	+11.95%
Feb 2026	$27.88	$30.22	+10.05%
Jan 2026	$27.18	$27.46	+0.84%
Dec 2025	$28.54	$27.23	-6.71%
Nov 2025	$42.97	$29.19	-32.52%

AGIO Share Price FAQs

What is Agios Pharmaceuticals, Inc. share price today?

Agios Pharmaceuticals, Inc. share price today is $31.83 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Agios Pharmaceuticals, Inc. stock?

The 52 week high of Agios Pharmaceuticals, Inc. stock is $46.00, while the 52 week low is $22.25 as of 10 Oct '26.

What is AGIO's market capitalisation today?

AGIO market capitalisation is $1.85B as of October 12, 2026, at 2:08 am IST.

What is AGIO's net income for the last quarter?

AGIO's net income for the last quarter is -100.70B USD.

What is the 5 year returns of AGIO?

The 5 year returns of AGIO is -32.23% as on 10 Oct '26.

What is the high & low stock price of AGIO today?

AGIO stock price hit a high of $32.12 and low of $31.55 as of 10 Oct '26.

Can I buy AGIO shares in India?

Yes. You can buy AGIO in India by opening an international trading account.